SPOTLIGHT -
Improving the Management of HNSCC: Next Steps
Dr Cesar Perez reacts to the utilization of next-generation sequencing in head and neck squamous cell carcinoma and highlights future areas of study.
HRAS Mutations in Head and Neck Cancer
The significance of studying strategies that target HRAS mutations in head and neck squamous cell carcinoma.
Precision Medicine in Head and Neck Cancer
Key takeaways from a paper that evaluated the efficacy of tipifarnib in recurrent and/or metastatic mHRAS head and neck squamous cell carcinoma.
Presentation: Tipifarnib in HNSCC With HRAS Mutations
Drs Cesar Perez and Victoria Meucci Villaflor review “Tipifarnib in Head and Neck Squamous Cell Carcinoma With HRAS Mutations” by Ho AL, et al.
